Showing results (51-60 of 219) with videos related to

Sort By:
Pageof 22
Journal of Neurovirology|October 7, 2018
Mechanisms of neuropathogenesis in HIV and HCV: similarities, differences, and unknownsAmeer Abutaleb, Sarah Kattakuzhy, Shyam Kottilil, et al.
Expert Review of Clinical Pharmacology|August 21, 2015
What does the pharmacological future of treating chronic hepatitis C look like?Emily L Heil, Lauren M Hynicka, Shyam Kottilil, et al.
Journal of Addiction Medicine|December 16, 2020
COVID-19 and Cannabidiol (CBD)Jag H Khalsa, Greg Bunt, Sanjay B Maggirwar, et al.
Frontiers in Immunology|February 15, 2021
IL-21-Deficient T Follicular Helper Cells Support B Cell Responses Through IL-27 in Patients With Chronic Hepatitis BArshi Khanam, Natarajan Ayithan, Lydia Tang, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 22, 2023
IFNL4 Genotype Frequencies in Asian Populations Support Shorter Duration Therapy with Sofosbuvir-Based Hepatitis C Virus Regimens to Increase the Number CuredThomas R O'Brien, Mei-Hsuan Lee, Eleanor Wilson, et al.
JAMA|May 2, 2018
Chronic Hepatitis B Infection: A ReviewLydia S Y Tang, Emily Covert, Eleanor Wilson, et al.
Antiviral Therapy|September 14, 2018
Sofosbuvir/velpatasvir/voxilaprevir: a highly effective option for retreatment of hepatitis C in difficult-to-treat patientsPoonam Mathur, Shyamasundaran Kottilil, Eleanor Wilson
Journal of Clinical and Translational Hepatology|January 15, 2019
Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral EraPoonam Mathur, Shyamasundaran Kottilil, Eleanor Wilson
BMC Infectious Diseases|December 5, 2020
Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infectionCody Orr, Wenjie Xu, Henry Masur, et al.
Pageof 22